ENVIRONMENTAL EXPOSURE TO FUNCTION OF LUNG EPITHELIAL STEM CELL BIOLOGY
Dr Clare Weeden
Laboratory Head
The Walter and Eliza Hall Institute of Medical Research (WEHI)
Melbourne, Australia
RESEARCHER PROFILE
Filmed in Melbourne, Australia | March 2025
Dr Clare Weeden has recently commenced as a Laboratory Head at WEHI in 2025, supported by the CSL Centenary Fellowship.
Dr Weeden specialises in lung epithelial cell biology in the context of homeostasis, inflammation, and lung cancer, particularly in people who don’t smoke. Her work endeavours to understand how past environmental exposures shape the responses of lung cells and the molecular mechanisms underlying this cellular recall, with the aim to develop novel early detection strategies for lung disease.
Dr Weeden completed her PhD studying lung squamous cell carcinoma initiation and treatment with Professor Marie-Liesse Asselin-Labat at WEHI, where she discovered distinct DNA repair abilities in lung stem cells that enabled their susceptibility to cancer, published in PLOS Biology.
Dr Weeden conducted postdoctoral research at WEHI and found that the pre-existing lung immune microenvironment had lasting effects on tumour immunogenicity and response to immunotherapy, published in Cancer Cell. She then continued her research on early tumour biology in Professor Charles Swanton’s laboratory at the Francis Crick Institute, London, where she was part of a team discovery that air pollution triggers inflammatory signalling in the lung that awakens previously dormant cells to initiate lung cancers in people who don’t smoke, published in Nature.
Dr Weeden is the past recipient of prestigious fellowships (Marie Sklodowska Curie Actions, Lung Foundation Australia Deep Manchanda Early Career Fellowship), research grants (Cancer Research UK, Mark Foundation, Cure Cancer/Cancer Australia) and has published 36 research publications with over 1000 citations.
Source: supplied
-
Investigating new approaches to target plaque inflammation in atherosclerosis
Associate Professor Peter Psaltis is an Academic Interventional Cardiologist who holds Level 2 NHMRC Career Development and National Heart Foundation Future Leader Fellowships. He has Faculty positions within the University of Adelaide, Central Adelaide Local Health Network (CALHN) and South Australian Health and Medical Research Institute (SAHMRI). Within SAHMRI, he is the Co-Theme Leader of the Lifelong Health, Program Leader of Heart and Vascular Health and Co-director of the Vascular Research Centre in the Lifelong Health Theme.
-
Life-changing donor milk for preterm babies
Dr Laura Klein is National Milk Research Leader at Australian Red Cross Lifeblood. Australian Red Cross Lifeblood is funded by Australian governments to provide life-giving blood, plasma, and transplantation and biological products.
Dr Klein works with clinicians and researchers across Australia to understand how donated breast milk can be used to improve outcomes for vulnerable babies. She’s passionate about generating evidence to improve the products and services that milk banks provide to donors and the families who receive donated breast milk.
-
Next generation nanomedicine and radiopharmaceuticals to treat cancer
Finding better ways of treating cancer, aside from finding a cure, aim to provide a better quality of life for those who suffer from it.
Professor Thurecht’s work focuses on nanomedicine and spans across the Australian Institute for Bioengineering and Nanotechnology and the Centre for Advanced Imaging, at the University of Queensland in Australia.
